Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition characterized by chronic inflammation that affects the bladder. The study was aimed at evaluating the effectiveness of intravesical platelet-rich plasma (PRP) injections in patients with IC/BPS.
We conducted a comprehensive search strategy to involve studies that investigate the efficacy of intravesical PRP injections or instillations over different time intervals. Various outcome measures were assessed, including pain scores, functional outcomes, urodynamic parameters, and surface expressions on the urothelium.
Our search strategy revealed 1,125 studies. After screening, ten articles met the inclusion criteria. Intravesical PRP significantly reduced the visual analog scale (VAS) compared with baseline scores. Several clinical trials reported significant improvements in the global response rate (GRA), O'Leary-Sant Symptom (OSS) questionnaire, Interstitial Cystitis Symptom Index (ICSI), and Interstitial Cystitis Problem Index (ICPI). Urodynamic parameters such as maximum flow rate (Qmax) and post-voiding residual (PVR) showed significant improvements in some studies.
The study concluded that intravesical PRP injections could be a promising effective treatment option for IC/BPS patients by their significant ability to reduce pain. However, improvement of urodynamic and functional outcomes is still not clear. Further large comparative trials are still warranted to assess the efficacy of PRP instillation.
International urogynecology journal. 2024 Jul 03 [Epub ahead of print]
Ahmed Soliman, Mariam Adel, Mohamed A Elnagar, Saif Elsonbaty, Ahmed El Hefnawy
Faculty of Medicine, Mansoura University, 6 Al Ashqar St., of El Gomhouria St, Mansoura, Egypt. ., Faculty of Medicine, Mansoura University, 6 Al Ashqar St., of El Gomhouria St, Mansoura, Egypt., Research Department, Mansoura Research Team (MRT), Mansoura, Egypt.